PharmaForceIQ announced it has acquired Aktana in a move the company says will merge its digital orchestration platform with Aktana’s AI-driven field Next-Best-Action capabilities, creating what it described as the industry’s first “optichannel-in-a-box” commercial engagement system for pharmaceutical companies.
The company said the combined offering is designed to unify brand and field strategy, improve executional alignment, and provide rapid measurement of commercial impact, with deployments that can go live in as little as six to eight weeks. PharmaForceIQ said it will integrate its modular, machine learning-powered platform with Aktana’s AI core to support scalability and ongoing innovation across the combined platform.
PharmaForceIQ described the transaction as an asset acquisition that will deepen its footprint in the United States while extending reach across markets in Latin America, Asia-Pacific, and Europe, the Middle East, and Africa. The company said the integration will enhance field engagement capabilities and expand predictive insights aimed at improving field team performance.
Aktana’s field Next-Best-Action platform is powered by its proprietary Knowledge Nexus dataset, which PharmaForceIQ said includes real-world insights from more than 85 validated use cases and is informed by more than 100 million field suggestions and over 5,000 tactics executed over 12 years. PharmaForceIQ cited outcomes it said have been demonstrated across clients, including a 36% lift in new-to-brand prescriptions, a 19% sales performance increase following a competitor launch among users of the platform, and an estimated 20 minutes per day saved per representative in manual planning and logging.
PharmaForceIQ also said optichannel engagement strategies spanning field and digital channels can drive gains across commercial functions, including higher script lift, improved adherence to brand strategy, increased healthcare professional engagement, and potential budget savings compared with traditional media buying models.
Derek Choy, PharmaForceIQ’s head of product and the former co-founder and chief product officer of Aktana, is expected to help bring Aktana’s field orchestration technology into the broader PharmaForceIQ platform. The company said Aktana has made significant enhancements over the past two years, including AI-powered communications planning, automated tactic optimization, and live strategic visibility to support healthcare professional journey design and execution.
Support: Canaccord Genuity served as the sole financial advisor on the transaction.
KEY QUOTES:
“We’re thrilled to add these new capabilities to deepen our orchestration engine, making PharmaForceIQ the industry’s only end-to-end go-to-market customer engagement platform. We will scale our work even more quickly across clients and other global pharma companies, including making field teams even smarter and more effective alongside our existing features that improve marketing performance.”
Hemal Somaiya, Chief Executive and Strategy Officer, PharmaForceIQ
“I am excited to bring our pioneering Field Orchestration platform to PharmaForceIQ. This move will take our product to the next level, enabling best-in-class orchestration across both field and digital. Our unified platform helps teams understand their customers even more deeply, enabling them to predict, orchestrate, and measure personalized journeys across the right field, digital, and P2P channels.”
Derek Choy, Head of Product, PharmaForceIQ; Former Co-Founder and Chief Product Officer, Aktana
